NIH-funded research Career grant

Understanding how alcohol affects muscle health in liver disease

Official title: Mechanisms of HIF1 alpha mediated dysregulated skeletal muscle proteostasis in alcoholic liver disease

Funded at Cleveland Clinic Lerner Com-Cwru · NIH-11032829 · Data updated 2026-11-12

This study looks at how drinking alcohol affects muscle health in people with alcoholic liver disease, aiming to understand why they often lose muscle and find ways to help improve their strength and well-being.

More Alcoholic Liver Disease research and trials

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionCleveland Clinic Lerner Com-Cwru
NIH-funded
Lab location1 site (Cleveland, United States)
Project startMarch 1, 2021
Project endFebruary 28, 2026
Funding year2025
Award (this year)$179,129
NIH project number5K08AA028794-05
Project IDNIH-11032829 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with alcoholic liver disease who are experiencing muscle loss or sarcopenia.

Less likely to help

Patients without alcoholic liver disease or those who do not exhibit muscle loss may not benefit from this research.

What this research studies

This research investigates the impact of alcohol use on skeletal muscle health in patients with alcoholic liver disease (ALD). It focuses on the mechanisms that lead to muscle loss, known as sarcopenia, which is common in ALD and linked to worse health outcomes. The study examines how alcohol consumption disrupts protein homeostasis and causes mitochondrial dysfunction, contributing to muscle deterioration. By exploring these underlying processes, the research aims to identify potential therapeutic targets for improving muscle health in affected patients.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that help preserve muscle mass and improve health outcomes for patients with alcoholic liver disease.

How similar studies have gone: Previous research has shown promising results in understanding muscle loss mechanisms in liver disease, but this specific approach focusing on HIF1α and alcohol's effects is relatively novel.

Where this research is happening

  • Cleveland Clinic Lerner Com-Cwru
    Cleveland, United States
    Active

Researchers

  • Principal investigator: Welch, Nicole — Cleveland Clinic Lerner Com-Cwru
  • Study coordinator: Welch, Nicole

Related research

Other NIH-funded projects on the same topics.

  • Microbiome and Innate Immune Response in Alcohol-Related Liver Disease

    Researchers are studying how gut bacteria and the body's first-line immune defenses contribute to liver damage from alcohol, with a focus on how a specific bacteria and its toxins affect disease severity.

    NIH research University of California, San Diego · La Jolla, United States · NIH-11543368

  • Lipotoxicity and Alcohol-Related Liver Disease

    This project studies how fatty acids cause liver cell damage in alcohol-related liver disease to help develop new treatments.

    NIH research University of North Carolina Greensboro · Greensboro, United States · NIH-11450399

  • NNMT as a Target to Treat Alcoholic Liver Disease

    A study to see if blocking an enzyme called NNMT can help people with alcoholic liver disease.

    NIH research University of Illinois at Chicago · Chicago, UNITED STATES · NIH-11380807

  • How gut fungi may drive alcohol-related liver damage

    Researchers are looking at whether specific fungi in the gut make liver damage from heavy drinking worse in people with alcohol-related liver disease.

    NIH research University of California, San Diego · La Jolla, United States · NIH-11378956

  • Heat shock protein 90 and alcohol-related liver disease: how macrophages fuel inflammation

    This project looks at how a cellular stress protein, HSP90, affects liver inflammation in people with alcohol-related liver disease by focusing on macrophages.

    NIH research Univ of Massachusetts Med Sch Worcester · Worcester, United States · NIH-11374847

  • Why alcohol-related liver disease can come back after a transplant

    Looking at whether an enzyme called CerS6 helps fat build up in the liver and whether measuring CerS6 can help detect or predict return of alcohol-related liver disease before or after a liver transplant.

    NIH research University of Washington · Seattle, United States · NIH-11329541

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.